ABSTRACT
test shows that their CD4 count is below 200 cells per 3 cubic millimeter of blood . Treatment of the HIV infections itself is rarely an emergency and is only initiated principally when the CD4 count of a patient falls below 500 cells per cubic millimeter of blood however, there are also other criteria used to initiate treatment.
It is recommended that people diagnosed with HIV who are yet to start taking drugs to manage the disease or those whose CD4 count falls below 200 cells per cubic millimeter of blood are prescribed Co-Trimoxazole to reduce the risk of PCP. This kind of treatment is called prophylaxis in other words: it is aimed at preventing the infection rather than treating it. Use of Co-Trimoxazole in HIV/AIDS infection is aimed at preventing and managing common opportunistic infections that will likely worsen HIV/AIDS infection and associated morbidity and mortality. The choice of Co-Trimoxazole is majorly because of its wide efficacy against these common infections, less interaction, low side effects profile and relatively low cost in comparison to other antibacterial agents with the same indications profile.
PCP is a potentially fatal illness that until now is the most common cause of death in people with Acquired Immunodeficiency Syndrome (AIDS) which is an advanced stage of HIV infection. PCP is now becoming less common as a result of effective HIV treatment, use of Co-Trimoxazole for prophylaxis, and better treatment for patients who develop PCP.
HIV/AIDS services are available at two levels-"comprehensive sites" (hospitals providing counselling, testing and treatment of HIV for PMTCT, pediatrics and adults including Tuberculosis/HIV integration) and "standalone sites" (hospitals providing Prevention of Mother to Child Transmission-PMTCT of HIV/AIDS services). By design of patient retention in HIV treatment, the comprehensive sites are more clientengaging and elaborate in services therefore, use of CoTrimoxazole is only common in this category of hospitals. Whereas for PMTCT sites, they are only designed to cater for pregnant women diagnosed with HIV infection whom after delivery and found to be stable are referred to comprehensive sites for continuation of care and treatment.
Therefore, data collection will be focused in comprehensive sites because they request for and receive Co-Trimoxazole on regular basis. There are a total of nine (9) comprehensive sites in Kebbi State.
In calculating the state-wide inventory level of CoTrimoxazole tablets, a summation is made of all inventories across all locations where these commodities are kept: hospitals, local government stores and central medical store in the state. However, in HIV/AIDS program in Kebbi State, these drugs are supplied from the regional warehouse directly to health facilities. In view of this, the local government stores and central medical store in the state do not stock these commodities as such; the stock position in the nine (9) comprehensive sites is representative of the entire state. Co-Trimoxazole tablets used in HIV/AIDS program are of three (3) types namely: Co-trimoxazole120 mg dispersible tablets (used for pediatric patients), Cotrimoxazole480 mg tablets (for adults), and Cotrimoxazole 960 mg tablets for adults as well.
HIV/AIDS SERVICE POINTS IN KEBBI STATE, NIGERIA

OVERVIEW OF INVENTORY CONTROL SYSTEM
Inventory refers to the number/quantity of stocked goods (drugs). It is required to be taken at different locations within a facility or within many locations of a supply network to precede the regular and planned course of production/requisition/purchase and stock of materials.
The continuous supply of quality Co-Trimoxazole can only be guaranteed through the selection, design, and proper implementation of an appropriate inventory control system. An inventory control system informs the EOP is usually less than the min stock level.
INVENTORY CONTROL SYSTEM IN PLACE IN NIGERIA
DEFINING DATA COLLECTION PERIOD
In Nigeria, the adopted inventory control system for the HIV/AIDS program is the max-min inventory control system. The max has been set at four (4) months of stock 5 while the min at two (2) months of stock . Therefore, commodities used in HIV/AIDS continuum of care are expected to fall within four and two months respectively. If the level of stock is more than four MoS, it means the system is over-stocked i.e., keeping more than it is desired to keep. On the other hand if the level of stock is less than two MoS, it means the system is understocked and will soon experience danger of stock out. 
BACKGROUND AND LITERATURE REVIEW
Assessing inventory level also known as stock status assessment is essentially finding out how long a stock will last (which is better referred to as month of stock). This is an important exercise in logistics as it gives insight on the inventory level of any commodity in the program and as well is a direct pointer about how well the logistics system is functioning. As much as it is a stock monitoring exercise it is as well an evaluative tool. The inventory control system used in Nigeria states that all commodities used in HIV/AIDS continuum of care should be maintained within an inventory level of two months of stock as minimum level and four months as maximum level. inventory control level . In light of research reports reviewed so far, this is the only state with optimal and ideal level of inventory as pre-defined by the national guidelines. All these implied that research on stock assessment of Co-Trimoxazole tablets revealed that only one state in Nigeria has recorded the optimal inventory level across all types of Co-Trimoxazole tablets used in the HIV/AIDS continuum of care.
PROBLEM STATEMENT/RESEARCH QUESTION
While Abubakar et al (2015) conducted their research from January-March, 2015, it is important to note that inventory level assessment is time-relevant. In other words, inventory assessment of one review period will differ from another because the determinants of stock assessment (stock on hand and bi-monthly consumption) cannot be the same for any two periods.
The results obtained in January-March, 2015 cannot be extrapolated forward or backward to any review period. They reported that only Co-Trimoxazole 960 mg tablets fell within the required inventory level while other types of Co-Trimoxazole were not within the required levels. The recommendation drawn from this research was to sustain techniques on logistics management of health commodities that will ensure all the stock levels remain within required inventory control system levels which will guarantee Co-Trimoxazole security and ready access to the clients that will need them and avoiding wastage across the levels.
The entire problem is that similar inventory level assessments of Co-Trimoxazole tablets in other states of Nigeria revealed lapses in commodity management because of all research reports seen so far, only one out of the thirty six states reported optimal inventory level across all types of Co-Trimoxazole tablets. More so, the research conducted by Abubakar et al in 2015, a year ago, revealed that only one type of Co-Trimoxazole (960 mg) is within the required inventory level in Kebbi State of Nigeria.
Owing to the fact that stock status assessment is timerelevant, the question to answer in this research is to find out whether the current inventory levels of all types of Co-Trimoxazole tablets (Co-Trimoxazole120 mg, CoTrimoxazole 480 mg and Co-Trimoxazole 960 mg) are in the required inventory level as specified by the inventory control system of HIV/AIDS program management of Nigeria.
METHODS
RESEARCH DESIGN
The research is primarily evaluative in context. This is so because the max-min inventory control system adopted in Nigeria stipulates a max quantity of four months of stock and a min quantity of two months of stock at the states level. It is therefore expected that stock levels at any given time should be within two and four months of stock under normal circumstances. Any variation seen reflects a deviation from the desired logistics system setting and calls for correction, adjustment or intervention to bring the system back to the normal-established levels. After collecting the useful data elements namely-stock on hand and bi-monthly consumption of CoTrimoxazole120 mg, 480 mg & 960 mg respectively, the data were processed using spreadsheets of MS Excel package.
Data from hospitals need only to be inputted in the first two rows of the spreadsheets, the last two rows were set to be auto-calculated or computed based on the contents of each cell in the first two rows by inserting appropriate formulae. A formula was inserted across the third row (AMC) which was to divide all contents of cells in the second row (bi-monthly consumption) by two. Another formula was inserted across the fourth row (MoS) which was to divide all contents of cells across the first row (SoH) by all the contents of cells across the third row (MoS).
After inputting all the data for different types of CoTrimoxazole tablets in separate figures of the MS Excel spreadsheets, bar charts were generated using the "Insert" chart option in the menu bar. The charts show the hospitals on the horizontal axis and MoS on the vertical axis.
After the above analyses which were done hospital by hospital, aggregates of data of each type of Co-
METHOD OF DATA COLLECTION
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Trimoxazole tablet were used to generate a state-wide inventory level of Co-Trimoxazole tablets from HIV/AIDS comprehensive health care centers. This spreadsheet was used to generate a bar chart showing the inventory level of the different types of Co-Trimoxazole tablets in one chart. In this chart, the MoS is on the horizontal axis while the types of Co-Trimoxazole tablets on the vertical axis.
DATA PRESENTATION/RESULTS
INVENTORY LEVEL OF CO-TRIMOXAZOLE120 mg TABLETS
The The charts show all hospitals visited on the horizontal axis while the month of stock is on the vertical axis. In other words, each column of the bar chart represents a hospital as appropriately labelled and the MoS even though shown on the vertical axis are as well shown by a data label above each column. This is a logistics malfunction as it points to the fact that the hospital kept recording wrong data which lead to requisitions of Co-Trimoxazole480 mg and this probably happened over a span of time for the hospital to have accumulated this amount of the drug. Moreover, there will be risk of expiry because the rate of bi-monthly consumption will take more than four years (103 months) to consume this drug. Very likely, some of the drugs if not evacuated will expire at the facility unused.
AGGREGATED RESULTS CO-TRIMOXAZOLE120 mg, 480 mg and 960 mg TABLETS IN KEBBI STATE
INVENTORY LEVEL OF CO-TRIMOXAZOLE120 mg TABLETS
INVENTORY LEVEL OF CO-TRIMOXAZOLE480 mg TABLETS
Other hospitals were below the 2 months min inventory level and they included: General Hospitals Argungu (MoS= 0), Jega (MoS= 1.3) and Kamba (MoS= 1.9), Martha Bamaiyi Memorial Hospital (MoS= 0.8) and Sir Yahaya Memorial Hospital (MoS=0). These hospitals were at risk of stock out because they had small quantities of this drug kept in stock which cannot last up to two months. General Hospitals Argungu (MoS= 8.9), Jega and Wasagu and Sir Yahaya Memorial Hospital had inventory levels above the max level of four months. By implication, they had stocked more than the hospitals require for optimal management of the commodity in question. While they may not be able to consume this commodity, Co-Trimoxazole960 mg is at risk of expiry before consumption because except General Hospital Jega which had a MoS of 4.2, the other two hospitals General Hospital Wasagu (MoS= 36) and Sir Yahaya Memorial Hospital (MoS= 29.3) have stocked CoTrimoxazole960 mg that will last for 36 months for the former and 29 months for the latter. Figure 8 above gives the summary of results of this research. The aim of this research was to assess the inventory level of Co-Trimoxazole tablets in Kebbi State by finding out how long stock of each type of CoTrimoxazole tablet will last and which of them is within the required quantity as specified by the inventory control system of Nigeria.
INVENTORY LEVEL OF CO-TRIMOXAZOLE960 mg TABLETS
AGGREGATED MONTH OF STOCK FOR CO-TRIMOXAZOLE TABLETS IN KEBBI STATE
Fig. 8: MoS of Co-Trimoxazole Tablets in Kebbi State
In the chart above, all types of Co-Trimoxazole tablets were not within the 2 months min and 4 months max inventory level.
Co-Trimoxazole120 mg had MoS of 1.9 which was too close to 2 MoS. It however has to be classified as below the inventory level of 2 months min.
Co-Trimoxazole480 mg had MoS of 1.4 which was quite well below the minimum inventory level of 2 months.
It thus means that Kebbi State is approaching a state of stock out of these commodities. While different results from all hospitals contributed to this, it is important to note that hospitals that are out of stock can request from other hospitals that have enough stock. When taken as a whole the entire state-wide picture of the commodities is still below the required minimum because hospitals that are out of stock collect from other hospitals that have stock all of which are in the same pool.
On the other hand, Co-Trimoxazole960 mg had MoS of 5.7 which was quite far above the max level of 4 months. The system is a bit saturated with Co-Trimoxazole960 mg.
Having conducted the research and obtained all data elements needed to formulate results and conclusion, it is important to discuss another dimension and implication of results obtained from this research.
Information was obtained from updated records of all the hospitals, the question to ask is: despite adequate record keeping, why were there variations from the yardstick of inventory control system? The answer could be none other than error in reporting during review periods.
FURTHER DISCUSSION
INVENTORY LEVELS BELOW THE MINIMUM
For hospitals with below the minimum level or those that were completely out of stock, the reason could be despite adequate and updated record keeping, the hospitals were not submitting bi-monthly requisitions using the Combined Report, Requisition, Issue and Receipt Form (CRRIRF). It thus means there was adequate commodity management at hospital level by keeping good record on the Inventory Control Cards (ICC) and daily worksheets but no reporting for the affected commodity line.
Generally this should be the assumption however; CoTrimoxazole480 mg and Co-Trimoxazole960 mg have a different interpretation of low inventory level.
In clinical practice, the use of Co-Trimoxazole480 mg and Co-Trimoxazole960 mg is interchangeable. While Co-Trimoxazole480 mg is a single strength taken as two tablets twice a day, Co-Trimoxazole960 mg is the double equivalent taken as one tablet twice a day. Therefore, a deficiency in one is not enough to question low level of inventory so far the hospital has adequate inventory of the other. In this regards, we need to study the results of Co-Trimoxazole480 mg and Co-Trimoxazole960 mg comparatively. In doing this, a hospital with low level of Co-Trimoxazole480 mg will be checked to see if the alternative Co-Trimoxazole960 mg is in adequate quantity. If a hospital has either type of Co-Trimoxazole in adequate quantity, it will be regarded as okay but low levels of both is a real program deficiency. However, it is important to note that an adequate quantity of both is not over-saturation of the system.
On the other hand, the use of Co-Trimoxazole120 mg is exclusively for pediatric patients (children). In comparing the results of Co-Trimoxazole480 mg and Co-Trimoxazole960 mg using Figure 9 above, the following interpretation can be made.
General Hospital Argungu had MoS of 0 for CoTrimoxazole480 mg and MoS of 8.9 for CoTrimoxazole960 mg. Even though it has one type of CoTrimoxazole in place of the other, the MoS of CoTrimoxazole960 mg is more than double the maximum level. As such it is expected the hospital will not make requisition of this drug for some time until the inventory falls within the required range.
General Hospital Jega had MoS of 1.3 for CoTrimoxazole480 mg and MoS of 4.2 for CoTrimoxazole960 mg. While the former was below the minimum level, the latter was slightly above the maximum level.
For General Hospital Koko, the MoS of CoTrimoxazole480 mg was 2.4 against MoS of 0 for CoTrimoxazole980mg. While the former was in adequate range, the latter was lacking. In this regard, dispensing Co-Trimoxazole will not be a problem as well.
The result from General Hospital Kamba revealed that the hospital had MoS of 1.9 for Co-Trimoxazole480 mg and MoS of 0 for Co-Trimoxazole960 mg. This is a bit worrisome as the former was below the minimum level while the latter is completely lacking. In this case adequate requisition has to be made to achieve the required inventory level.
General Hospital Wasagu had MoS of 3.0 for CoTrimoxazole480 mg and MoS of 36 for CoTrimoxazole960 mg. Co-Trimoxazole480 mg was in the required range while the hospital had overstocked its system with Co-Trimoxazole960 mg. The best practice will be to stop requisition of both types of Co-Trimoxazole tablets until the MoS of 36 months is brought between 2-4 months. This should be the case even if CoTrimoxazole480 mg will become out of stock because its alternative is available for use by patients.
In Martha Bamaiyi Memorial Hospital, the MoS of CoTrimoxazole480 mg was 0.8 while the MoS of CoTrimoxazole960 mg is 0. The hospital was in a situation of stock out as Co-Trimoxazole960 mg is already finished while the other is approaching stock out.
General Hospital Yauri had MoS of 103.4 for CoTrimoxazole480 mg and MoS of 1.7 for Co-Trimoxazole 960 mg. The MoS of Co-Trimoxazole480 mg was the most bizarre in this research. The best approach to solve this problem could be to stop making further requisition for both drugs and make efforts to transfer as much quantity out as possible of Co-Trimoxazole480 mg. As it was, the hospital will take more than four years to dispense all of its Co-Trimoxazole480 mg which will lead to expiry of most of it definitely. That is why the hospital has to transfer some out to other facilities will low level of Co-Trimoxazole480 mg.
Sir Yahaya Memorial Hospital had MoS of 0 for CoTrimoxazole480 mg and MoS of 29.3 for CoTrimoxazole960 mg. While the former was out of stock, the latter was more than enough for the hospital as it is seven times more than the maximum level recommended. The facility may stop requisition of both drugs until a time comes when the MoS of CoTrimoxazole960 mg is in the required range. All inventory levels above the maximum level are reflective of one of two things. First, it could be the hospital is making arithmetical errors in quantities to order. Or it could be the hospital made the right requisition but the issuer at the Central Medical Store interpreted the result differently. In bi-monthly reporting, Co-Trimoxazole tablets are reported in tablets and not in packs. An error can occur in converting the number of tablets to packs which can result in over or under-supply. Secondly, hospitals may be requesting for drugs blindly without information on average monthly consumption and stock on hand.
INVENTORY LEVELS ABOVE THE MAXIMUM
CONCLUSION
RECOMMENDATIONS
The aim of this study which was to assess the inventory level of Co-Trimoxazole tablets in HIV/AIDS program of Kebbi State, Nigeria has been achieved. Applying the principle of inventory control system of Nigeria, 4 months of maximum stock level and 2 months of minimum stock level, the study found out that none of Co-Trimoxazole120 mg, Co-Trimoxazole480 mg and Co-Trimoxazole960 mg was within this required range. Therefore, the inventory level of Co-Trimoxazole tablets in the HIV/AIDS program of Kebbi State, Nigeria was not optimal for the period this research was conducted.
Across the entire state, the inventory level of CoTrimoxazole120 mg was 1.9 MoS, and that of CoTrimoxazole480 mg was 1.4 MoS while the inventory level of Co-Trimoxazole960 mg was 5.7 MoS.
It can be inferred that the inventory control system of CoTrimoxazole in Kebbi State has declined further. This is in light of the fact that Abubakar et al (2015) reported only Co-Trimoxazole960 mg was in the inventory control range as of March 2015. This study found out that none of the types of Co-Trimoxazole tablets is within inventory control range.
Even though the study found out that records were well kept, variations from record keeping and adequate inventory level point to obvious inability of hospital staff concerned to use logistics data in making requisitions. The problem might as well be error in calculating "quantity to order". For results that were below the minimum level, it could as well be due to non-reporting for resupply.
Owing to the results obtained and conclusion drawn thereafter, the following recommendations can be made on the subject of this research.
1.
There should be inter-facility transfer of CoTrimoxazole tablets from places of high stock to places of low stock volume in order to bring all facilities to the inventory control level pre-defined by the program. In doing this, expiry dates of the commodities in question should be considered in such a way that hospitals with high consumption be given commodities whose expiry dates are near, whereas hospitals with low consumption be given commodities with far expiry. 2.
For hospitals that have unusually high amount of any type of the commodity in question, requisition of that commodity or its substitute should be put on hold until stock level is within the inventory control range.
3.
Staff responsible for making requisitions should be adequately trained to use essential data elements in placing orders, these are: stock on hand, consumption and losses and adjustments. By studying these and taking into account previous records, stock-piling of commodities will be greatly minimized.
4.
Staff in charge of commodity management should also be trained on how to use logistics data to make informed decisions regarding commodity management.
5.
Record keeping should be perfected most especially the filling of daily worksheets which is exactly the quantity of drugs dispensed to patients per day. 6 .
This type of research should be conducted at least once in a quarter to have a picture of stock levels in hospitals. By this, stock monitoring and evaluation of the performance of the logistics system can be known.
7.
Kebbi State Government should key into this as "consumption" of these commodities is an essential element in quantification forecasting for future needs of its citizens when the donor funding eventually terminates as it shall when the project life span is reached.
